Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 183   

Articles published

PFE 27.93 +0.10 (0.36%)
price chart
UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda
Fast Money Halftime Report Final Trade From October 13 · Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review · What Are The Best-Selling Drugs Of 2014?
Anti-abuse label approved for painkiller Embeda  The State
Related articles »  
Pfizer Inc. Stock Fails To Break Out: Is It Headed Back Down?
Pfizer Inc. (NYSE: PFE) shareholders have experienced the short-term euphoria of seeing their stock rally a massive 10 percent from August to September.
Related articles »  
Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?
According to Susanna Kim of ABC News, dividend yield and dividend growth comprised 90% of the total nominal returns for investors in the S&P 500 between 1910 and 2010.
Drug Manufacturers � Major
Pfizer Inc was incorporated under the laws of the State of Delaware on June 2, 1942. It is a research-based, biopharmaceutical company.
Alabama federal judge: Time to end nationwide litigation against Pfizer anti ...
FLORENCE, Alabama - All of the nearly 2,900 lawsuits claiming pharmaceutical giant Pfizer Inc.'s smoking cessation drug Chantix triggered suicidal thoughts and other psychological problems in patients have been settled - for about $300 million - so the ...
UPDATE 1-FDA panel votes to keep severe warning on Pfizer anti-smoking drug
(Adds details, company comments, shares). By Vidya L Nathan. Oct 16 (Reuters) - Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to ...
Dow Jones (DJIA) Today: Pfizer (PFE) Lower
Pfizer has a market cap of $175.64 billion and is part of the health care sector and drugs industry. Shares are down 9.1% year-to-date as of Friday's close.
Related articles »  
Interesting December Stock Options for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer PFE -1.74% Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from ...
Related articles »  
Pfizer's Breast Cancer Drug Gets Priority Review Designation
Pfizer Inc. (PFE) announced today that the New Drug Application (NDA) for its drug palbociclib has received �Priority Review Designation� from the US Food and Drug Administration (FDA).
Stock Update (NYSE:PFE): Pfizer Announces FDA Acceptance Of Palbociclib ...  Jutia Group
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With ...  MarketWatch
Related articles »  
MedGenesis Enters Into Agreement with Pfizer Inc. for Potential Treatments for ...
VICTORIA, BRITISH COLUMBIA--(Marketwired - Sept. 16, 2014) - MedGenesis Therapeutix Inc. ("MedGenesis"), a privately held biotechnology company focused on the development and precision delivery of definitive treatments for neurologic diseases, ...
Related articles »